LONZOR Trademark

Trademark Overview


On Monday, April 10, 2017, a trademark application was filed for LONZOR with the United States Patent and Trademark Office. The USPTO has given the LONZOR trademark a serial number of 87404854. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Monday, June 27, 2022. This trademark is owned by Novartis AG. The LONZOR trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; Pharmaceutical preparations for the preve...
lonzor

General Information


Serial Number87404854
Word MarkLONZOR
Filing DateMonday, April 10, 2017
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateMonday, June 27, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of kidney diseases; Pharmaceutical preparations for the prevention and treatment of diabetes; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical preparations for the prevention and treatment of allergies; Pharmaceutical products for the prevention and treatment of bone diseases; Pharmaceutical products for the prevention and treatment of respiratory diseases and asthma
Translation of Words in MarkThe wording "LONZOR" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, June 27, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, June 27, 2022ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Monday, June 27, 2022ABANDONMENT - AFTER INTER PARTES DECISION
Monday, June 27, 2022OPPOSITION TERMINATED NO. 999999
Monday, June 27, 2022OPPOSITION SUSTAINED NO. 999999
Wednesday, June 22, 2022OPPOSITION INSTITUTED NO. 999999
Wednesday, June 22, 2022OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 21, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 26, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, December 13, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, December 13, 2019ASSIGNED TO LIE
Wednesday, October 30, 2019ASSIGNED TO EXAMINER
Monday, May 13, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, November 13, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, May 10, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, October 27, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, April 27, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 27, 2017LETTER OF SUSPENSION E-MAILED
Thursday, April 27, 2017SUSPENSION LETTER WRITTEN
Thursday, April 27, 2017ASSIGNED TO EXAMINER
Saturday, April 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 13, 2017NEW APPLICATION ENTERED